Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 1/2 5Phase NA 3Phase 3 1

Status

Completed 657Terminated 218Unknown 111Recruiting 108Active not recruiting 102Withdrawn 54Not yet recruiting 26Suspended 5Enrolling by invitation 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 22Lymphoid 10Thoracic 9CNS 9Other hematologic neoplasm 8Genitourinary 8Sarcoma 7Head & Neck 5Dermatologic 5Breast 5Gynecologic 4Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 2Myeloid 2Endocrine 1

Conditions

Melanoma 5Recurrence 1

Interventions

talimogene laherparepvec 1sargramostim 1romiplostim 1cobimetinib 1Propranolol 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Dermatologic × Clear all
NCT05756556 2024-02-01

T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma

ImmVira Pharma Co. Ltd

Phase 2 Suspended
68 enrolled
Dermatologic

Melanoma

NCT04427306 2023-09-15

Neoadjuvant T-VEC in High Risk Early Melanoma

University of California, Davis

Phase 2 Suspended
6 enrolled
Dermatologic

Melanoma

NCT01988831 2019-05-10

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

University Hospital, Geneva

Phase 2 Suspended
450 enrolled
Dermatologic

Melanoma, Recurrence

NCT00278122 2013-12-10

Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

University of Virginia

Phase 2 Suspended
42 enrolled
Dermatologic

Melanoma

NCT00042497 2005-06-24

Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma

Anosys

Phase 2 Suspended
60 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡